Association of PICP Serum Marker in Patients With LVSD

Stopped early

Conditions studied: Systolic Dysfunction

In brief

The purpose of this study is to determine if the carboxy-terminal of procollagen type I (PICP) can be a useful marker of different degrees of myocardial fibrosis.

Key facts

Study ID

NCT00232388

Run by

Texas Tech University Health Sciences Center

People needed

45

Starts

2005-09-01

Expected to finish

2007-09-01

Last updated by the study team

2015-10-07

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Evidence of left ventricular systolic dysfunction (measured LVEF% less than 35%) measured by echocardiography within the previous three months at the time of enrollment
• Greater than or equal to 18 years of age
• Greater than or equal to 110 pounds in weight

You may not qualify if…

• Non-sinus rhythm at the time of enrollment

Where it is running

• TTUHSC — Lubbock, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.